Vaxcyte Income Before Tax vs Cost Of Revenue Analysis

PCVX Stock  USD 93.98  2.53  2.77%   
Vaxcyte financial indicator trend analysis is much more than just breaking down Vaxcyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxcyte is a good investment. Please check the relationship between Vaxcyte Income Before Tax and its Cost Of Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Income Before Tax vs Cost Of Revenue

Income Before Tax vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxcyte Income Before Tax account and Cost Of Revenue. At this time, the significance of the direction appears to have pay attention.
The correlation between Vaxcyte's Income Before Tax and Cost Of Revenue is -0.93. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Vaxcyte, assuming nothing else is changed. The correlation between historical values of Vaxcyte's Income Before Tax and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Vaxcyte are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Income Before Tax i.e., Vaxcyte's Income Before Tax and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.93
Relationship DirectionNegative 
Relationship StrengthSignificant

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Vaxcyte income statement and is an important metric when analyzing Vaxcyte profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Cost Of Revenue

Cost of Revenue is found on Vaxcyte income statement and represents the costs associated with goods and services Vaxcyte provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Vaxcyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxcyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.Selling General Administrative is likely to rise to about 63.7 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 364.6 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization1.8M9.2M3.2M4.0M
Net Interest Income337K8.4M62.9M66.1M

Vaxcyte fundamental ratios Correlations

0.920.950.99-0.940.99-0.990.540.730.2-0.730.990.86-0.730.880.521.00.960.870.850.94-0.67-0.760.930.910.76
0.920.990.9-0.790.87-0.940.450.44-0.12-0.60.880.78-0.60.740.580.880.840.760.730.98-0.53-0.480.990.990.58
0.950.990.93-0.850.91-0.960.560.53-0.04-0.680.920.82-0.680.830.560.920.90.790.80.97-0.61-0.560.970.970.68
0.990.90.93-0.961.0-0.980.540.750.23-0.690.990.84-0.690.890.420.990.970.880.860.92-0.64-0.780.910.890.77
-0.94-0.79-0.85-0.96-0.970.93-0.6-0.81-0.440.74-0.96-0.840.74-0.95-0.36-0.96-0.98-0.92-0.92-0.840.70.82-0.81-0.77-0.88
0.990.870.911.0-0.97-0.970.570.80.3-0.741.00.86-0.740.910.441.00.980.890.880.9-0.69-0.820.880.850.81
-0.99-0.94-0.96-0.980.93-0.97-0.51-0.66-0.190.75-0.97-0.890.75-0.88-0.57-0.97-0.96-0.9-0.86-0.970.690.68-0.95-0.93-0.76
0.540.450.560.54-0.60.57-0.510.620.11-0.70.570.63-0.70.740.30.570.660.360.720.37-0.69-0.610.370.360.77
0.730.440.530.75-0.810.8-0.660.620.53-0.670.80.71-0.670.740.30.80.770.610.720.46-0.67-0.990.430.390.76
0.2-0.12-0.040.23-0.440.3-0.190.110.53-0.460.260.31-0.460.45-0.020.260.370.530.370.04-0.5-0.48-0.04-0.120.55
-0.73-0.6-0.68-0.690.74-0.740.75-0.7-0.67-0.46-0.74-0.861.0-0.86-0.63-0.75-0.83-0.74-0.75-0.621.00.65-0.59-0.55-0.84
0.990.880.920.99-0.961.0-0.970.570.80.26-0.740.87-0.740.890.51.00.970.860.850.9-0.69-0.820.880.860.78
0.860.780.820.84-0.840.86-0.890.630.710.31-0.860.87-0.860.860.670.870.890.810.910.79-0.84-0.680.770.740.87
-0.73-0.6-0.68-0.690.74-0.740.75-0.7-0.67-0.461.0-0.74-0.86-0.86-0.63-0.75-0.83-0.74-0.75-0.621.00.65-0.59-0.55-0.84
0.880.740.830.89-0.950.91-0.880.740.740.45-0.860.890.86-0.860.40.890.970.890.930.79-0.84-0.740.750.710.95
0.520.580.560.42-0.360.44-0.570.30.3-0.02-0.630.50.67-0.630.40.50.460.410.410.53-0.6-0.260.540.540.37
1.00.880.920.99-0.961.0-0.970.570.80.26-0.751.00.87-0.750.890.50.970.870.860.9-0.7-0.820.880.860.78
0.960.840.90.97-0.980.98-0.960.660.770.37-0.830.970.89-0.830.970.460.970.910.920.88-0.79-0.780.850.820.89
0.870.760.790.88-0.920.89-0.90.360.610.53-0.740.860.81-0.740.890.410.870.910.830.87-0.71-0.610.820.770.8
0.850.730.80.86-0.920.88-0.860.720.720.37-0.750.850.91-0.750.930.410.860.920.830.77-0.72-0.70.740.710.96
0.940.980.970.92-0.840.9-0.970.370.460.04-0.620.90.79-0.620.790.530.90.880.870.77-0.55-0.491.00.990.63
-0.67-0.53-0.61-0.640.7-0.690.69-0.69-0.67-0.51.0-0.69-0.841.0-0.84-0.6-0.7-0.79-0.71-0.72-0.550.64-0.52-0.47-0.84
-0.76-0.48-0.56-0.780.82-0.820.68-0.61-0.99-0.480.65-0.82-0.680.65-0.74-0.26-0.82-0.78-0.61-0.7-0.490.64-0.46-0.43-0.73
0.930.990.970.91-0.810.88-0.950.370.43-0.04-0.590.880.77-0.590.750.540.880.850.820.741.0-0.52-0.461.00.59
0.910.990.970.89-0.770.85-0.930.360.39-0.12-0.550.860.74-0.550.710.540.860.820.770.710.99-0.47-0.431.00.54
0.760.580.680.77-0.880.81-0.760.770.760.55-0.840.780.87-0.840.950.370.780.890.80.960.63-0.84-0.730.590.54
Click cells to compare fundamentals

Vaxcyte Account Relationship Matchups

Vaxcyte fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets65.7M392.8M324.3M1.0B1.4B1.5B
Other Current Liab7.5M17.1M11.4M18.9M116.5M122.4M
Total Current Liabilities11.1M46.9M28.7M40.5M145.3M152.6M
Total Stockholder Equity(106.4M)345.8M284.0M953.6M1.2B1.3B
Other Liab259K122K96K9K8.1K7.7K
Net Tangible Assets(106.4M)345.8M284.0M953.6M1.1B1.2B
Retained Earnings(109.3M)(198.6M)(298.6M)(522.1M)(924.4M)(878.2M)
Accounts Payable3.4M29.8M6.8M9.8M14.6M10.8M
Cash59.0M386.2M69.0M834.7M397.5M290.5M
Other Assets584K550K5.0M5.4M1.00.95
Cash And Short Term Investments59.0M386.2M246.0M931.4M1.1B1.1B
Common Stock Shares Outstanding48.9M51.1M51.9M64.9M97.2M57.4M
Capital Surpluse1.3M3.0M544.4M582.8M670.3M703.8M
Total Liab172.1M47.0M40.3M52.6M167.4M96.9M
Total Current Assets61.7M389.0M256.3M942.6M1.1B1.2B
Common Stock7K54K56K82K98K102.9K
Property Plant Equipment3.4M3.3M35.9M31.6M36.4M38.2M
Property Plant And Equipment Net3.4M3.3M35.9M31.6M110.6M116.2M
Net Debt(58.8M)(386.2M)(52.2M)(816.7M)(368.2M)(386.6M)
Non Current Assets Total4.0M3.8M68.0M63.6M312.0M327.6M
Non Currrent Assets Other584K550K5.0M5.4M38.7M40.6M
Liabilities And Stockholders Equity65.7M392.8M324.3M1.0B1.4B1.5B
Non Current Liabilities Total161.0M122K11.6M12.0M22.1M43.8M
Capital Lease Obligations161K0.016.8M17.9M29.2M30.7M
Other Current Assets2.7M2.5M9.2M5.3M15.7M16.5M
Other Stockholder Equity3.0M151.5M582.8M1.5B2.2B2.3B
Net Invested Capital(106.4M)345.8M284.0M953.6M1.2B1.3B
Accumulated Other Comprehensive Income(160.3M)(392.8M)(241K)(361K)179K188.0K
Capital Stock7K54K56K82K98K55.6K
Non Current Liabilities Other242K112K96K9K8.1K7.7K
Net Working Capital50.7M342.1M227.6M902.0M950.6M998.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.